Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02274012
Title Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment of HER2 Amplified Advanced Gastric, Gastroesophageal Junction and Esophageal Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Balazs Halmos

gastroesophageal junction adenocarcinoma

esophageal carcinoma

stomach carcinoma


Afatinib + Paclitaxel

Age Groups: adult
Covered Countries

No variant requirements are available.